Diamond-Blackfan Anemia 6

Search Trials
Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload
Status:
Completed
Last Changed:
Aug 27, 2014
First Changed:
Jan 25, 2008
Disease(s):
Transfusional Iron Overload
Intervention(s):
Core Study: DeferasiroxCore Study: DeferoxamineExtension: deferoxamine to deferasiroxExtension: deferasirox to deferoxamineDeferasiroxDeferoxamine
A Study Assessing the Efficacy and Safety of Deferasirox in Patients With Transfusion-dependent Iron Overload
Status:
Completed
Last Changed:
Feb 11, 2020
First Changed:
Sep 15, 2005
Disease(s):
Transfusion-dependent Iron Overload
Intervention(s):
Deferasirox
Related Hematopoietic Stem Cell Transplantation (HSCT) for Genetic Diseases of Blood Cells
Status:
Terminated
Last Changed:
Feb 27, 2017
First Changed:
Jul 31, 2015
Disease(s):
Stem Cell Transplantation
Intervention(s):
Cyclophosphamide Dose Level 1Cyclophosphamide Dose Level 2Cyclophosphamide Dose Level 3Cyclophosphamide Dose Level 4
Allogeneic Bone Marrow Transplantation for the Treatment of Genetic Disorders of Erythropoiesis
Status:
Completed
Last Changed:
Sep 12, 2008
First Changed:
Dec 21, 2007
Disease(s):
Genetic Disorders
Intervention(s):
Busulfan, Cyclophosphamide, BMD

Connect. Empower. Inspire.